Iron deficiency anemia in pregnant women

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The aims of this research article are (i) to report new results of a populationbasedcohort study and (ii) to summarize the recent knowledge regarding the risk ofiron deficiency anemia in pregnant women for adverse birth outcomes and theeffective treatment of this pathological condition during pregnancy. The study designwas the comparison the rate of preterm birth and low birthweight newborns ofpregnant women with iron deficiency anemia according to the treatment of ironalone (N=1,576), iron + folic acid (N=4,419), folic acid alone (N=149) and withoutiron (and folic acid) treatment (N=214), in addition of pregnant women without irondeficiency anemia (N=31,793) as a reference group. Both iron deficiency anemiain pregnant women and the above adverse birth outcomes of newborns without birthdefects were medically recorded in prenatal maternity logbook and discharge summaryof women after delivery from inpatient obstetric clinics in the populationbasedHungarian Case-Control Surveillance System of Congenital Abnormalities.There was a high rate of preterm births (15.0%) in the newborns of anemicpregnant women without iron treatment. The rate of preterm birth was only somewhathigher (10.7%) in the newborns of anemic pregnant women supplemented by ironcompared to the figure of reference group (9.2%). However, anemic pregnantwomen with iron + folic acid treatment had a significantly lower rate of preterm births (8.2%). The secondary findings of the study are the higher prevalenceof constipation, hemorrhoids and hypotension in anemic pregnant women. Thesefindings are discussed on the basis of data in the literature. In conclusion the higherrisk of preterm birth of newborn infants born to pregnant women with irondeficiency anemia can be reduced by iron treatment and prevented by iron + folicacid supplementation.

Original languageEnglish
Title of host publicationIron Deficiency and its Complications
PublisherNova Science Publishers, Inc.
Pages103-119
Number of pages17
ISBN (Print)9781613248546
Publication statusPublished - 2012

Fingerprint

Iron-Deficiency Anemias
Premature Birth
Pregnant Women
Iron
Folic Acid
Newborn Infant
Anemia
Obstetric Delivery
Parturition
Therapeutics
Hemorrhoids
Constipation
Hypotension
Inpatients
Pregnancy
Research

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Czeizel, E., & Bánhidy, F. (2012). Iron deficiency anemia in pregnant women. In Iron Deficiency and its Complications (pp. 103-119). Nova Science Publishers, Inc..

Iron deficiency anemia in pregnant women. / Czeizel, E.; Bánhidy, F.

Iron Deficiency and its Complications. Nova Science Publishers, Inc., 2012. p. 103-119.

Research output: Chapter in Book/Report/Conference proceedingChapter

Czeizel, E & Bánhidy, F 2012, Iron deficiency anemia in pregnant women. in Iron Deficiency and its Complications. Nova Science Publishers, Inc., pp. 103-119.
Czeizel E, Bánhidy F. Iron deficiency anemia in pregnant women. In Iron Deficiency and its Complications. Nova Science Publishers, Inc. 2012. p. 103-119
Czeizel, E. ; Bánhidy, F. / Iron deficiency anemia in pregnant women. Iron Deficiency and its Complications. Nova Science Publishers, Inc., 2012. pp. 103-119
@inbook{4ad9db31b1824068929c409462d8630d,
title = "Iron deficiency anemia in pregnant women",
abstract = "The aims of this research article are (i) to report new results of a populationbasedcohort study and (ii) to summarize the recent knowledge regarding the risk ofiron deficiency anemia in pregnant women for adverse birth outcomes and theeffective treatment of this pathological condition during pregnancy. The study designwas the comparison the rate of preterm birth and low birthweight newborns ofpregnant women with iron deficiency anemia according to the treatment of ironalone (N=1,576), iron + folic acid (N=4,419), folic acid alone (N=149) and withoutiron (and folic acid) treatment (N=214), in addition of pregnant women without irondeficiency anemia (N=31,793) as a reference group. Both iron deficiency anemiain pregnant women and the above adverse birth outcomes of newborns without birthdefects were medically recorded in prenatal maternity logbook and discharge summaryof women after delivery from inpatient obstetric clinics in the populationbasedHungarian Case-Control Surveillance System of Congenital Abnormalities.There was a high rate of preterm births (15.0{\%}) in the newborns of anemicpregnant women without iron treatment. The rate of preterm birth was only somewhathigher (10.7{\%}) in the newborns of anemic pregnant women supplemented by ironcompared to the figure of reference group (9.2{\%}). However, anemic pregnantwomen with iron + folic acid treatment had a significantly lower rate of preterm births (8.2{\%}). The secondary findings of the study are the higher prevalenceof constipation, hemorrhoids and hypotension in anemic pregnant women. Thesefindings are discussed on the basis of data in the literature. In conclusion the higherrisk of preterm birth of newborn infants born to pregnant women with irondeficiency anemia can be reduced by iron treatment and prevented by iron + folicacid supplementation.",
author = "E. Czeizel and F. B{\'a}nhidy",
year = "2012",
language = "English",
isbn = "9781613248546",
pages = "103--119",
booktitle = "Iron Deficiency and its Complications",
publisher = "Nova Science Publishers, Inc.",

}

TY - CHAP

T1 - Iron deficiency anemia in pregnant women

AU - Czeizel, E.

AU - Bánhidy, F.

PY - 2012

Y1 - 2012

N2 - The aims of this research article are (i) to report new results of a populationbasedcohort study and (ii) to summarize the recent knowledge regarding the risk ofiron deficiency anemia in pregnant women for adverse birth outcomes and theeffective treatment of this pathological condition during pregnancy. The study designwas the comparison the rate of preterm birth and low birthweight newborns ofpregnant women with iron deficiency anemia according to the treatment of ironalone (N=1,576), iron + folic acid (N=4,419), folic acid alone (N=149) and withoutiron (and folic acid) treatment (N=214), in addition of pregnant women without irondeficiency anemia (N=31,793) as a reference group. Both iron deficiency anemiain pregnant women and the above adverse birth outcomes of newborns without birthdefects were medically recorded in prenatal maternity logbook and discharge summaryof women after delivery from inpatient obstetric clinics in the populationbasedHungarian Case-Control Surveillance System of Congenital Abnormalities.There was a high rate of preterm births (15.0%) in the newborns of anemicpregnant women without iron treatment. The rate of preterm birth was only somewhathigher (10.7%) in the newborns of anemic pregnant women supplemented by ironcompared to the figure of reference group (9.2%). However, anemic pregnantwomen with iron + folic acid treatment had a significantly lower rate of preterm births (8.2%). The secondary findings of the study are the higher prevalenceof constipation, hemorrhoids and hypotension in anemic pregnant women. Thesefindings are discussed on the basis of data in the literature. In conclusion the higherrisk of preterm birth of newborn infants born to pregnant women with irondeficiency anemia can be reduced by iron treatment and prevented by iron + folicacid supplementation.

AB - The aims of this research article are (i) to report new results of a populationbasedcohort study and (ii) to summarize the recent knowledge regarding the risk ofiron deficiency anemia in pregnant women for adverse birth outcomes and theeffective treatment of this pathological condition during pregnancy. The study designwas the comparison the rate of preterm birth and low birthweight newborns ofpregnant women with iron deficiency anemia according to the treatment of ironalone (N=1,576), iron + folic acid (N=4,419), folic acid alone (N=149) and withoutiron (and folic acid) treatment (N=214), in addition of pregnant women without irondeficiency anemia (N=31,793) as a reference group. Both iron deficiency anemiain pregnant women and the above adverse birth outcomes of newborns without birthdefects were medically recorded in prenatal maternity logbook and discharge summaryof women after delivery from inpatient obstetric clinics in the populationbasedHungarian Case-Control Surveillance System of Congenital Abnormalities.There was a high rate of preterm births (15.0%) in the newborns of anemicpregnant women without iron treatment. The rate of preterm birth was only somewhathigher (10.7%) in the newborns of anemic pregnant women supplemented by ironcompared to the figure of reference group (9.2%). However, anemic pregnantwomen with iron + folic acid treatment had a significantly lower rate of preterm births (8.2%). The secondary findings of the study are the higher prevalenceof constipation, hemorrhoids and hypotension in anemic pregnant women. Thesefindings are discussed on the basis of data in the literature. In conclusion the higherrisk of preterm birth of newborn infants born to pregnant women with irondeficiency anemia can be reduced by iron treatment and prevented by iron + folicacid supplementation.

UR - http://www.scopus.com/inward/record.url?scp=84892255546&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892255546&partnerID=8YFLogxK

M3 - Chapter

SN - 9781613248546

SP - 103

EP - 119

BT - Iron Deficiency and its Complications

PB - Nova Science Publishers, Inc.

ER -